Immunotherapy before surgery for oral cavity cancer
Treatments studied
Part of Cancer, Mouth & dental clinical trials.
This study tests if giving immunotherapy before surgery helps treat oral cavity cancer. Researchers will look for markers in your biopsy that predict how well the treatment works.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older.
- You have oral cavity cancer (stage II to IVB) that can be removed with surgery.
- Your tumor is at least 2 cm and a small biopsy can be taken safely.
- You have not had chemotherapy or immunotherapy for this cancer before.
- You do not have an active autoimmune disease or other cancer that needs treatment.
- You are willing to use birth control if needed, and not pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether giving a type of radiation therapy (proton or photon) along with the immunotherapy drug pembrolizumab before surgery is safe and effective for people with certain oral cavity cancers. The goal is to see if this combination can shrink the tumor and improve outcomes.
This study tests a combination of an immunotherapy drug (Benmelstobart), a targeted therapy (Anlotinib), and standard chemotherapy given before surgery for advanced oral cancer. The goal is to see if this approach can shrink the tumor and improve outcomes.
This trial tests two drugs, pembrolizumab and cetuximab, given before surgery to shrink advanced mouth cancer linked to betel-nut chewing. It aims to improve treatment outcomes and shrink tumors.
This Phase 2 trial tests pembrolizumab and an investigational drug (IO102-103) given before surgery for certain non-bulky head and neck squamous cell cancers. The goal is to shrink the cancer and improve chances of cure by treating it before the operation.
This trial tests a new immunotherapy drug (tirellizumab) combined with chemotherapy before surgery for early-stage oral cancer. It aims to see if this combination can help shrink the tumor and improve outcomes.
This trial tests whether giving nivolumab (an immunotherapy drug) before surgery helps treat oral squamous cell carcinoma (a type of mouth cancer). Nivolumab helps your immune system fight cancer cells.
Hear when a new Oral Cavity Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.